# Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

> **NCT03807947** · NA · UNKNOWN · sponsor: **Humanitas Clinical and Research Center** · enrollment: 74 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatocellular Carcinoma Non-resectable

## Interventions

- **PROCEDURE:** Radial TAE - Bland embolization with 40-100 Microparticles
- **PROCEDURE:** Transfemoral TAE - Bland embolization with 40-100 Microparticles

## Key facts

- **NCT ID:** NCT03807947
- **Lead sponsor:** Humanitas Clinical and Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2019-12
- **Final completion:** 2020-04
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2019-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807947, "Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03807947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*